Lilly & Co. (LLY) and Boehringer Ingelheim Report FDA Approves sNDAs to Include Data in Product Labels for Synjardy, Synjardy XR, and Glyxambi
Tweet Send to a Friend
The U.S. Food and Drug Administration (FDA) approved supplemental New Drug Applications for three type 2 diabetes medicines within the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
